PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 63 results · Obesity & Weight Management  · Clear
🔒 Subscribers only
AUTH/2273/10/09
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Lilly v Novo Nordisk
Clauses: NONE
🔒 Subscribers only
AUTH/2269/9/09
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breach of undertaking over The Times supplement remaining on website
The PMCPA Director identified information suggesting Novo Nordisk continued to use a supplement to The Times, contrary to an undertaking given in an earlier case (AUTH/2202/1/09).Novo Nordisk had p…
Clauses: 2
🔒 Subscribers only
AUTH/2234/5/09
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk ruled in breach for repeated pre-licence promotion of Victoza (liraglutide) via website
Eli Lilly complained that Novo Nordisk continued to promote Victoza (liraglutide) before UK marketing authorisation, despite a recent prior ruling (AUTH/2202/1/09). Victoza marketing authorisation …
Clauses: NONE
🔒 Subscribers only
AUTH/2099/2/08
Certification & Approval Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Roche
A former Roche employee complained about (1) supply of Xenical (orlistat) to a bogus health professional and (2) Roche funding of a clinic (Case AUTH/2099/2/08).An article in the Financial Times (1…
Clauses: NONE
🔒 Subscribers only
AUTH/2157/8/08
Off-label Promotion Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi-Aventis — Acomplia (rimonabant)
A practice pharmacist complained about a four-page leavepiece, “Nice news for Norman”, promoting Acomplia (rimonabant), left by a Sanofi-Aventis representative.The complainant alleged the front…
Clauses: 7.2
🔒 Subscribers only
AUTH/2164/9/08
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Takeda
Merck Sharp & Dohme complained about a two-page journal advertisement (ref AB080313) for Actos (pioglitazone) and Competact (pioglitazone/metformin) issued by Takeda UK Limited, which appeared …
Clauses: NONE
🔒 Subscribers only
AUTH/2158/8/08
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
A pharmacist practitioner complained that Sanofi-Aventis did not respond after he returned a reply-paid card for Acomplia (rimonabant).The card stated NICE had recommended Acomplia for obesity and …
Clauses: NONE
🔒 Subscribers only
AUTH/1992/4/07
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
A pharmacist practitioner complained about a Sanofi-Aventis representative’s conduct during promotion of Lantus (insulin glargine) and Acomplia (rimonabant).Lantus allegation: the rep briefly sho…
Clauses: NONE
🔒 Subscribers only
AUTH/2010/6/07
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
A general practitioner complained about Sanofi-Aventis’ promotion of Acomplia (rimonabant), focusing on the claim: “An estimated 50% of the effects of Acomplia on Cardiometabolic Risk Factors a…
Clauses: NONE
🔒 Subscribers only
AUTH/2056/10/07
Data & Publications Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eli Lilly v Novo Nordisk
Eli Lilly complained about a Novo Nordisk journal advertisement for Levemir (insulin detemir) in Diabetes Update, Autumn 2007 (ref UK/LM/0707/0052).The ad used an underwater photo of five overweigh…
Clauses: 9.1,4.2
🔒 Subscribers only
AUTH/2045/9/07
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Eli Lilly complained about a double-page Pulse (Aug 2007) “Advertisement Feature” for Levemir (insulin detemir), styled as an advertorial: “Levemir in type 2 diabetes an overview for primary …
Clauses: NONE
🔒 Subscribers only
AUTH/1976/3/07
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
A general practitioner complained about a Sanofi-Aventis journal advertisement for Acomplia (rimonabant) published in Update (March 2007) (ref ACO 07/1049).The ad highlighted three cardiometabolic …
Clauses: NONE
🔒 Subscribers only
AUTH/1844/6/06
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi-Aventis breached the Code with unsolicited “horizon scanning” email about unlicensed rimonaba
The head of prescribing at a Primary Care Trust (PCT) received an email from Sanofi-Aventis (end of May 2006) about the licensing status of rimonabant and how to obtain further information.The emai…
Clauses: NONE
🔒 Subscribers only
AUTH/1871/7/06
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi-Aventis Acomplia (rimonabant) GP ad
A doctor complained about a Sanofi-Aventis advertisement for Acomplia (rimonabant) published in GP.The ad headline stated: “Cardiometabolic risk factors in overweight patients can be where you le…
Clauses: NONE
🔒 Subscribers only
AUTH/1882/8/06
Off-label Promotion Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
A general practitioner complained about an Acomplia (rimonabant) page tag issued by Sanofi-Aventis and attached to a full-page MIMS advertisement for Acomplia.The tag featured only the brand name �…
Clauses: 9.1,18.3
← Prev 1 2 3 Page 3 of 3 — 63 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews